BioCentury
ARTICLE | Clinical News

OBE022: Phase I started

August 22, 2016 7:00 AM UTC

ObsEva began a double-blind, placebo-controlled, U.K. Phase I trial to evaluate single and multiple ascending doses of oral OBE022 in 70 healthy female volunteers. ...